pmc-enju-pas Home  

PMC:2889865 / 10742-14966 JSONTXT 18 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T5145 0-11 JJ denotes Cooperative
T5146 12-21 NN denotes induction
T5147 22-24 IN denotes of
T5148 25-34 NN denotes cytokines
T5149 35-37 IN denotes by
T5150 38-42 NN denotes AP-1
T5151 43-46 CC denotes and
T5152 47-52 NN denotes NF-κB
T5153 53-55 TO denotes To
T5154 56-63 RB denotes further
T5155 64-76 VB denotes characterize
T5156 77-80 DT denotes the
T5157 81-92 NN denotes involvement
T5158 93-95 IN denotes of
T5159 96-101 NN denotes NF-κB
T5160 102-104 IN denotes in
T5161 105-113 NN denotes cytokine
T5162 114-124 NN denotes regulation
T5163 124-125 -COMMA- denotes ,
T5164 126-128 PRP denotes we
T5165 129-136 VB denotes treated
T5166 137-142 NN denotes cells
T5167 143-147 IN denotes with
T5168 148-150 DT denotes an
T5169 151-156 NN denotes NF-κB
T5170 157-167 NN denotes activation
T5171 168-177 NN denotes inhibitor
T5172 178-179 -LRB- denotes (
T5173 179-182 NN denotes NAI
T5174 182-183 -RRB- denotes )
T5175 185-188 DT denotes The
T5176 189-196 NN denotes results
T5177 197-203 VB denotes showed
T5178 204-208 IN denotes that
T5179 209-212 NN denotes NAI
T5180 213-224 RB denotes selectively
T5181 225-239 VB denotes down-regulated
T5182 240-245 NN denotes NF-κB
T5183 246-256 NN denotes activation
T5184 257-258 -LRB- denotes (
T5185 258-265 NN denotes figures
T5186 266-268 NN denotes 4a
T5187 269-272 CC denotes and
T5188 273-275 NN denotes 4b
T5189 275-276 -RRB- denotes )
T5190 277-280 CC denotes and
T5191 281-284 VB denotes did
T5192 285-288 RB denotes not
T5193 289-294 VB denotes alter
T5194 295-299 NN denotes AP-1
T5195 300-308 NN denotes activity
T5196 309-310 -LRB- denotes (
T5197 310-317 NN denotes figures
T5198 318-320 NN denotes 4c
T5199 321-324 CC denotes and
T5200 325-327 NN denotes 4d
T5201 327-328 -RRB- denotes )
T5202 330-338 NN denotes Exposure
T5203 339-341 IN denotes of
T5204 342-348 NN denotes Jurkat
T5205 349-356 NN denotes T-cells
T5206 357-359 TO denotes to
T5207 360-363 NN denotes NAI
T5208 364-372 VB denotes resulted
T5209 373-375 IN denotes in
T5210 376-377 DT denotes a
T5211 378-384 JJ denotes modest
T5212 385-394 NN denotes reduction
T5213 395-397 IN denotes of
T5214 398-403 NN denotes CXCL8
T5215 404-413 VB denotes following
T5216 414-417 NN denotes PMA
T5217 418-426 NN denotes exposure
T5218 426-427 -COMMA- denotes ,
T5219 428-433 IN denotes while
T5220 434-436 PRP denotes it
T5221 437-440 VB denotes did
T5222 441-444 RB denotes not
T5223 445-450 VB denotes alter
T5224 451-454 DT denotes the
T5225 455-460 NN denotes CXCL8
T5226 461-468 NN denotes release
T5227 469-478 VB denotes following
T5228 479-481 NN denotes HK
T5229 482-484 FW denotes E.
T5230 485-489 FW denotes coli
T5231 490-498 NN denotes exposure
T5232 499-500 -LRB- denotes (
T5233 500-506 NN denotes figure
T5234 507-509 NN denotes 5a
T5235 509-510 -RRB- denotes )
T5236 512-515 NN denotes NAI
T5237 516-519 VB denotes did
T5238 520-523 RB denotes not
T5239 524-530 VB denotes affect
T5240 531-534 NN denotes TNF
T5241 535-545 NN denotes expression
T5242 546-547 -LRB- denotes (
T5243 547-553 NN denotes figure
T5244 554-556 NN denotes 5b
T5245 556-557 -RRB- denotes )
T5246 558-568 VB denotes indicating
T5247 569-573 IN denotes that
T5248 574-579 NN denotes NF-κB
T5249 580-582 VB denotes is
T5250 583-586 RB denotes not
T5251 587-590 DT denotes the
T5252 591-595 JJ denotes main
T5253 596-605 NN denotes regulator
T5254 606-608 IN denotes of
T5255 609-614 NN denotes CXCL8
T5256 615-617 CC denotes or
T5257 618-621 NN denotes TNF
T5258 622-631 VB denotes following
T5259 632-638 CC denotes either
T5260 639-642 NN denotes PMA
T5261 643-645 CC denotes or
T5262 646-648 NN denotes HK
T5263 649-651 FW denotes E.
T5264 652-656 FW denotes coli
T5265 657-665 NN denotes exposure
T5266 666-668 IN denotes in
T5267 669-675 NN denotes Jurkat
T5268 676-683 NN denotes T-cells
T5269 685-687 IN denotes In
T5270 688-696 NN denotes contrast
T5271 696-697 -COMMA- denotes ,
T5272 698-701 NN denotes NAI
T5273 702-710 VB denotes resulted
T5274 711-713 IN denotes in
T5275 714-715 DT denotes a
T5276 716-724 JJ denotes complete
T5277 725-735 NN denotes inhibition
T5278 736-738 IN denotes of
T5279 739-743 NN denotes IL-6
T5280 744-753 VB denotes following
T5281 754-757 NN denotes PMA
T5282 758-766 NN denotes exposure
T5283 767-770 CC denotes and
T5284 771-772 DT denotes a
T5285 773-775 CD denotes 45
T5286 775-776 NN denotes %
T5287 777-787 NN denotes inhibition
T5288 788-797 VB denotes following
T5289 798-800 NN denotes HK
T5290 801-803 FW denotes E.
T5291 804-808 FW denotes coli
T5292 809-817 NN denotes exposure
T5293 818-819 -LRB- denotes (
T5294 819-825 NN denotes figure
T5295 826-828 NN denotes 5c
T5296 828-829 -RRB- denotes )
T5297 829-830 -COMMA- denotes ,
T5298 831-841 VB denotes suggesting
T5299 842-844 DT denotes an
T5300 845-856 NN denotes involvement
T5301 857-859 IN denotes of
T5302 860-865 NN denotes NF-κB
T5303 866-868 IN denotes in
T5304 869-873 NN denotes IL-6
T5305 874-884 NN denotes regulation
T15991 896-906 NN denotes Inhibition
T15992 907-909 IN denotes of
T15993 910-915 NN denotes NF-κB
T15994 916-924 NN denotes activity
T15995 925-927 IN denotes by
T15996 928-931 NN denotes NAI
T15997 933-939 NN denotes Jurkat
T15998 940-947 NN denotes T-cells
T15999 948-952 VB denotes were
T16000 953-964 VB denotes transfected
T16001 965-969 IN denotes with
T16002 970-980 NN denotes luciferase
T16003 981-989 NN denotes reporter
T16004 990-998 NN denotes plasmids
T16005 999-1009 VB denotes containing
T16006 1010-1016 CC denotes either
T16007 1017-1022 NN denotes NF-κB
T16008 1023-1025 CC denotes or
T16009 1026-1030 NN denotes AP-1
T16010 1031-1041 JJ denotes cis-acting
T16011 1042-1050 NN denotes elements
T16012 1052-1055 DT denotes The
T16013 1056-1061 NN denotes cells
T16014 1062-1066 VB denotes were
T16015 1067-1076 VB denotes incubated
T16016 1077-1081 IN denotes with
T16017 1082-1087 NN denotes NF-κB
T16018 1088-1098 NN denotes activation
T16019 1099-1108 NN denotes inhibitor
T16020 1109-1110 -LRB- denotes (
T16021 1110-1113 NN denotes NAI
T16022 1113-1114 -RRB- denotes )
T16023 1115-1118 IN denotes for
T16024 1119-1120 CD denotes 1
T16025 1121-1122 NN denotes h
T16026 1123-1131 VB denotes followed
T16027 1132-1134 IN denotes by
T16028 1135-1146 NN denotes stimulation
T16029 1147-1151 IN denotes with
T16030 1152-1155 NN denotes PMA
T16031 1156-1157 -LRB- denotes (
T16032 1157-1160 CD denotes 162
T16033 1161-1163 NN denotes nM
T16034 1163-1164 -COMMA- denotes ,
T16035 1165-1166 NN denotes A
T16036 1167-1170 CC denotes and
T16037 1171-1172 NN denotes C
T16038 1172-1173 -RRB- denotes )
T16039 1174-1176 CC denotes or
T16040 1177-1179 NN denotes HK
T16041 1180-1182 FW denotes E.
T16042 1183-1187 FW denotes coli
T16043 1188-1189 -LRB- denotes (
T16044 1189-1190 CD denotes 5
T16045 1191-1192 NN denotes ×
T16046 1193-1196 CD denotes 107
T16047 1197-1203 NNP denotes CFU/ml
T16048 1203-1204 -COMMA- denotes ,
T16049 1205-1206 NN denotes B
T16050 1207-1210 CC denotes and
T16051 1211-1212 NN denotes D
T16052 1212-1213 -RRB- denotes )
T16053 1214-1217 IN denotes for
T16054 1218-1220 CD denotes 24
T16055 1221-1223 NN denotes h.
T16056 1224-1225 -LRB- denotes (
T16057 1225-1226 NN denotes A
T16058 1226-1227 -COMMA- denotes ,
T16059 1228-1229 NN denotes B
T16060 1229-1230 -RRB- denotes )
T16061 1231-1236 NN denotes NF-κB
T16062 1236-1237 -COMMA- denotes ,
T16063 1238-1241 CC denotes but
T16064 1242-1245 RB denotes not
T16065 1246-1247 -LRB- denotes (
T16066 1247-1248 NN denotes C
T16067 1248-1249 -COMMA- denotes ,
T16068 1250-1251 NN denotes D
T16069 1251-1252 -RRB- denotes )
T16070 1253-1257 NN denotes AP-1
T16071 1258-1261 VB denotes was
T16072 1262-1271 VB denotes inhibited
T16073 1273-1284 JJ denotes Statistical
T16074 1285-1297 NN denotes significance
T16075 1298-1302 IN denotes from
T16076 1303-1306 DT denotes the
T16077 1307-1315 JJ denotes positive
T16078 1316-1323 NN denotes control
T16079 1324-1325 -LRB- denotes (
T16080 1325-1331 NN denotes PMA/HK
T16081 1332-1334 FW denotes E.
T16082 1335-1339 FW denotes coli
T16083 1339-1340 -RRB- denotes )
T16084 1341-1344 VB denotes was
T16085 1345-1355 VB denotes determined
T16086 1356-1361 VB denotes using
T16087 1362-1369 NN denotes Student
T16088 1369-1371 POS denotes 's
T16089 1372-1379 NN denotes t-test.
T16090 1380-1381 -LRB- denotes (
T16091 1381-1382 NN denotes n
T16092 1383-1384 SYM denotes =
T16093 1385-1386 CD denotes 4
T16094 1386-1387 -RRB- denotes )
T16095 1389-1397 NN denotes Controls
T16096 1398-1402 VB denotes were
T16097 1403-1406 VB denotes set
T16098 1407-1409 TO denotes to
T16099 1410-1411 CD denotes 1
T5306 2183-2187 NN denotes Ca2+
T5307 2188-2191 VB denotes was
T5308 2192-2200 VB denotes observed
T5309 2201-2203 TO denotes to
T5310 2204-2212 VB denotes increase
T5311 2213-2217 NN denotes AP-1
T5312 2218-2226 NN denotes activity
T5313 2227-2228 -LRB- denotes (
T5314 2228-2234 NN denotes figure
T5315 2235-2237 NN denotes 1c
T5316 2237-2238 -RRB- denotes )
T5317 2239-2242 CC denotes and
T5318 2243-2249 VB denotes reduce
T5319 2250-2255 NN denotes NF-κB
T5320 2256-2264 NN denotes activity
T5321 2265-2266 -LRB- denotes (
T5322 2266-2272 NN denotes figure
T5323 2273-2275 NN denotes 2e
T5324 2275-2276 -RRB- denotes )
T5325 2276-2277 -COLON- denotes ;
T5326 2278-2287 RB denotes therefore
T5327 2287-2288 -COMMA- denotes ,
T5328 2289-2291 PRP denotes we
T5329 2292-2299 VB denotes exposed
T5330 2300-2307 NN denotes T-cells
T5331 2308-2310 TO denotes to
T5332 2311-2312 DT denotes a
T5333 2313-2316 NN denotes PKC
T5334 2317-2326 NN denotes inhibitor
T5335 2327-2335 RB denotes together
T5336 2336-2340 IN denotes with
T5337 2341-2344 NN denotes PMA
T5338 2345-2347 TO denotes to
T5339 2348-2357 VB denotes determine
T5340 2358-2361 PRP-DOLLAR- denotes its
T5341 2362-2368 NN denotes effect
T5342 2369-2371 IN denotes on
T5343 2372-2380 NN denotes cytokine
T5344 2381-2391 NN denotes expression
T5345 2393-2403 NN denotes Inhibition
T5346 2404-2406 IN denotes of
T5347 2407-2410 NN denotes PKC
T5348 2411-2418 VB denotes reduced
T5349 2419-2424 NN denotes CXCL8
T5350 2425-2432 NN denotes release
T5351 2433-2437 IN denotes from
T5352 2438-2439 CD denotes 7
T5353 2440-2445 NN denotes ng/ml
T5354 2446-2448 TO denotes to
T5355 2449-2450 CD denotes 3
T5356 2451-2456 NN denotes ng/ml
T5357 2457-2462 IN denotes while
T5358 2463-2465 PRP denotes it
T5359 2466-2469 VB denotes had
T5360 2470-2471 DT denotes a
T5361 2472-2478 JJ denotes modest
T5362 2479-2485 NN denotes effect
T5363 2486-2488 IN denotes on
T5364 2489-2493 NN denotes IL-6
T5365 2494-2497 CC denotes and
T5366 2498-2501 NN denotes TNF
T5367 2502-2503 -LRB- denotes (
T5368 2503-2509 NN denotes figure
T5369 2510-2514 NN denotes 6a-c
T5370 2514-2515 -RRB- denotes )
T5371 2517-2521 DT denotes This
T5372 2522-2530 VB denotes prompted
T5373 2531-2533 PRP denotes us
T5374 2534-2536 TO denotes to
T5375 2537-2541 VB denotes test
T5376 2542-2545 DT denotes the
T5377 2546-2552 NN denotes effect
T5378 2553-2555 IN denotes of
T5379 2556-2559 NN denotes JNK
T5380 2560-2570 NN denotes inhibition
T5381 2571-2573 IN denotes on
T5382 2574-2585 JJ denotes PMA-induced
T5383 2586-2594 NN denotes cytokine
T5384 2595-2605 NN denotes expression
T5385 2607-2610 NN denotes JNK
T5386 2611-2613 VB denotes is
T5387 2614-2622 VB denotes involved
T5388 2623-2625 IN denotes in
T5389 2626-2629 DT denotes the
T5390 2630-2640 NN denotes regulation
T5391 2641-2643 IN denotes of
T5392 2644-2645 DT denotes a
T5393 2646-2655 NN denotes multitude
T5394 2656-2658 IN denotes of
T5395 2659-2668 JJ denotes different
T5396 2669-2682 NN denotes transcription
T5397 2683-2690 NN denotes factors
T5398 2690-2691 -COMMA- denotes ,
T5399 2692-2701 VB denotes including
T5400 2702-2705 DT denotes the
T5401 2706-2721 NN denotes phosphorylation
T5402 2722-2725 CC denotes and
T5403 2726-2736 NN denotes activation
T5404 2737-2739 IN denotes of
T5405 2740-2745 NN denotes c-Jun
T5406 2745-2746 -COMMA- denotes ,
T5407 2747-2752 NN denotes c-Fos
T5408 2753-2756 CC denotes and
T5409 2757-2760 NN denotes p53
T5410 2760-2761 -COMMA- denotes ,
T5411 2762-2769 VB denotes leading
T5412 2770-2772 TO denotes to
T5413 2773-2781 JJ denotes cellular
T5414 2782-2791 NN denotes apoptosis
T5415 2792-2793 -LRB- denotes [
T5416 2793-2795 CD denotes 26
T5417 2795-2796 -RRB- denotes ]
T5418 2798-2808 NN denotes Inhibition
T5419 2809-2811 IN denotes of
T5420 2812-2815 DT denotes the
T5421 2816-2819 NN denotes JNK
T5422 2820-2828 NN denotes pathways
T5423 2829-2837 VB denotes resulted
T5424 2838-2840 IN denotes in
T5425 2841-2842 DT denotes a
T5426 2843-2858 NN denotes down-regulation
T5427 2859-2861 IN denotes of
T5428 2862-2866 CC denotes both
T5429 2867-2872 NN denotes CXCL8
T5430 2873-2876 CC denotes and
T5431 2877-2881 NN denotes IL-6
T5432 2881-2882 -COMMA- denotes ,
T5433 2883-2888 IN denotes while
T5434 2889-2891 DT denotes no
T5435 2892-2897 JJ denotes clear
T5436 2898-2904 NN denotes effect
T5437 2905-2908 VB denotes was
T5438 2909-2917 VB denotes observed
T5439 2918-2920 IN denotes on
T5440 2921-2924 NN denotes TNF
T5441 2925-2935 NN denotes expression
T5442 2936-2937 -LRB- denotes (
T5443 2937-2943 NN denotes figure
T5444 2944-2948 NN denotes 6a-c
T5445 2948-2949 -RRB- denotes )
T5446 2951-2959 NN denotes Analysis
T5447 2960-2962 IN denotes of
T5448 2963-2967 NN denotes mRNA
T5449 2968-2974 NN denotes levels
T5450 2975-2980 VB denotes using
T5451 2981-2988 NN denotes RT-qPCR
T5452 2989-2990 -LRB- denotes (
T5453 2990-2995 NN denotes table
T5454 2996-2997 CD denotes 2
T5455 2997-2998 -RRB- denotes )
T5456 2999-3005 VB denotes showed
T5457 3006-3010 IN denotes that
T5458 3011-3014 NN denotes PMA
T5459 3015-3022 VB denotes induced
T5460 3023-3027 CC denotes both
T5461 3028-3032 NN denotes il-6
T5462 3033-3036 CC denotes and
T5463 3037-3042 NN denotes cxcl8
T5464 3043-3047 NN denotes mRNA
T5465 3048-3049 -LRB- denotes (
T5466 3049-3057 JJ denotes 5.1-fold
T5467 3058-3061 CC denotes and
T5468 3062-3067 CD denotes 111.8
T5469 3068-3072 RB denotes fold
T5470 3073-3085 RB denotes respectively
T5471 3085-3086 -RRB- denotes )
T5472 3088-3096 NN denotes Addition
T5473 3097-3099 IN denotes of
T5474 3100-3103 DT denotes the
T5475 3104-3109 NN denotes NF-κB
T5476 3110-3119 NN denotes inhibitor
T5477 3120-3123 NN denotes NAI
T5478 3124-3127 CC denotes and
T5479 3128-3131 DT denotes the
T5480 3132-3135 NN denotes JNK
T5481 3136-3145 NN denotes inhibitor
T5482 3146-3153 VB denotes reduced
T5483 3154-3157 DT denotes the
T5484 3158-3162 NN denotes il-6
T5485 3163-3173 NN denotes expression
T5486 3174-3179 IN denotes below
T5487 3180-3185 JJ denotes basal
T5488 3186-3192 NN denotes levels
T5489 3194-3196 IN denotes In
T5490 3197-3205 NN denotes contrast
T5491 3205-3206 -COMMA- denotes ,
T5492 3207-3212 IN denotes while
T5493 3213-3216 DT denotes the
T5494 3217-3222 NN denotes cxcl8
T5495 3223-3229 NN denotes levels
T5496 3230-3234 VB denotes were
T5497 3235-3245 VB denotes suppressed
T5498 3246-3248 IN denotes by
T5499 3249-3252 DT denotes the
T5500 3253-3257 JJ denotes same
T5501 3258-3268 NN denotes treatments
T5502 3269-3272 DT denotes the
T5503 3273-3279 NN denotes levels
T5504 3280-3288 VB denotes remained
T5505 3289-3297 JJ denotes elevated
T5506 3298-3303 IN denotes above
T5507 3304-3309 JJ denotes basal
T5508 3310-3315 NN denotes level
T16538 3327-3338 NN denotes Involvement
T16539 3339-3341 IN denotes of
T16540 3342-3345 NN denotes PKC
T16541 3346-3349 CC denotes and
T16542 3350-3353 NN denotes JNK
T16543 3354-3356 IN denotes in
T16544 3357-3365 NN denotes cytokine
T16545 3366-3376 NN denotes expression
T16546 3378-3384 NN denotes Jurkat
T16547 3385-3392 NN denotes T-cells
T16548 3393-3397 VB denotes were
T16549 3398-3407 VB denotes incubated
T16550 3408-3412 IN denotes with
T16551 3413-3417 NN denotes PKC-
T16552 3418-3421 CC denotes and
T16553 3422-3425 NN denotes JNK
T16554 3426-3436 NN denotes inhibitors
T16555 3437-3440 IN denotes for
T16556 3441-3442 CD denotes 1
T16557 3443-3444 NN denotes h
T16558 3445-3453 VB denotes followed
T16559 3454-3456 IN denotes by
T16560 3457-3468 NN denotes stimulation
T16561 3469-3473 IN denotes with
T16562 3474-3477 NN denotes PMA
T16563 3478-3479 -LRB- denotes (
T16564 3479-3482 CD denotes 162
T16565 3483-3485 NN denotes nM
T16566 3485-3486 -RRB- denotes )
T16567 3487-3490 IN denotes for
T16568 3491-3493 CD denotes 24
T16569 3494-3496 NN denotes h.
T16570 3497-3498 -LRB- denotes (
T16571 3498-3499 NN denotes A
T16572 3499-3500 -RRB- denotes )
T16573 3501-3506 NN denotes CXCL8
T16574 3507-3517 NN denotes expression
T16575 3518-3521 VB denotes was
T16576 3522-3531 VB denotes inhibited
T16577 3532-3534 IN denotes in
T16578 3535-3536 DT denotes a
T16579 3537-3551 JJ denotes dose-dependent
T16580 3552-3558 NN denotes manner
T16581 3559-3561 IN denotes by
T16582 3562-3566 CC denotes both
T16583 3567-3578 NN denotes inhibitors.
T16584 3579-3580 -LRB- denotes (
T16585 3580-3581 NN denotes B
T16586 3581-3582 -RRB- denotes )
T16587 3583-3588 NN denotes JNK-I
T16588 3589-3597 VB denotes revealed
T16589 3598-3599 DT denotes a
T16590 3600-3608 JJ denotes stronger
T16591 3609-3619 JJ denotes inhibitory
T16592 3620-3626 NN denotes effect
T16593 3627-3629 IN denotes on
T16594 3630-3634 NN denotes IL-6
T16595 3635-3645 NN denotes expression
T16596 3646-3650 IN denotes than
T16597 3651-3654 DT denotes the
T16598 3655-3661 NN denotes PKC-I.
T16599 3662-3663 -LRB- denotes (
T16600 3663-3664 NN denotes C
T16601 3664-3665 -RRB- denotes )
T16602 3666-3669 NN denotes TNF
T16603 3670-3680 NN denotes expression
T16604 3681-3684 VB denotes was
T16605 3685-3688 RB denotes not
T16606 3689-3697 VB denotes affected
T16607 3698-3700 IN denotes by
T16608 3701-3707 DT denotes either
T16609 3708-3717 NN denotes inhibitor
T16610 3719-3730 JJ denotes Statistical
T16611 3731-3743 NN denotes significance
T16612 3744-3748 IN denotes from
T16613 3749-3752 DT denotes the
T16614 3753-3761 JJ denotes positive
T16615 3762-3769 NN denotes control
T16616 3770-3771 -LRB- denotes (
T16617 3771-3774 NN denotes PMA
T16618 3774-3775 -RRB- denotes )
T16619 3776-3779 VB denotes was
T16620 3780-3790 VB denotes determined
T16621 3791-3796 VB denotes using
T16622 3797-3804 NN denotes Student
T16623 3804-3806 POS denotes 's
T16624 3807-3814 NN denotes t-test.
T16625 3815-3816 -LRB- denotes (
T16626 3816-3817 NN denotes n
T16627 3818-3819 SYM denotes =
T16628 3820-3821 CD denotes 3
T16629 3821-3822 -RRB- denotes )
T17075 3833-3839 NN denotes Jurkat
T17076 3840-3847 NN denotes T-cells
T17077 3848-3852 VB denotes were
T17078 3853-3860 VB denotes treated
T17079 3861-3865 IN denotes with
T17080 3866-3868 CD denotes 10
T17081 3869-3871 NN denotes nM
T17082 3872-3875 NN denotes NAI
T17083 3875-3876 -COMMA- denotes ,
T17084 3877-3879 CD denotes 10
T17085 3880-3882 NN denotes μM
T17086 3883-3888 NN denotes JNK-I
T17087 3889-3893 NN denotes or10
T17088 3894-3896 NN denotes nM
T17089 3897-3902 NN denotes PKC-I
T17090 3903-3906 IN denotes for
T17091 3907-3908 CD denotes 2
T17092 3909-3910 NN denotes h
T17093 3911-3919 VB denotes followed
T17094 3920-3922 IN denotes by
T17095 3923-3932 NN denotes induction
T17096 3933-3937 IN denotes with
T17097 3938-3941 CD denotes 162
T17098 3942-3944 NN denotes nM
T17099 3945-3948 NN denotes PMA
T17100 3949-3952 IN denotes for
T17101 3953-3955 CD denotes 24
T17102 3956-3957 NN denotes h
R13004 T15991 T15992 arg1Of Inhibition,of
R13005 T15991 T15995 arg1Of Inhibition,by
R13006 T15994 T15992 arg2Of activity,of
R13007 T15994 T15993 arg1Of activity,NF-κB
R13008 T15996 T15995 arg2Of NAI,by
R13009 T15998 T15997 arg1Of T-cells,Jurkat
R13010 T15998 T15999 arg1Of T-cells,were
R13011 T15998 T16000 arg2Of T-cells,transfected
R13012 T16000 T15999 arg2Of transfected,were
R13013 T16000 T16001 arg1Of transfected,with
R13014 T16004 T16001 arg2Of plasmids,with
R13015 T16004 T16002 arg1Of plasmids,luciferase
R13016 T16004 T16003 arg1Of plasmids,reporter
R13017 T16004 T16005 arg1Of plasmids,containing
R13018 T16007 T16008 arg1Of NF-κB,or
R13019 T16009 T16008 arg2Of AP-1,or
R13020 T16011 T16005 arg2Of elements,containing
R13021 T16011 T16006 arg1Of elements,either
R13022 T16011 T16007 arg1Of elements,NF-κB
R13023 T16011 T16009 arg1Of elements,AP-1
R13024 T16011 T16010 arg1Of elements,cis-acting
R13025 T16013 T16012 arg1Of cells,The
R13026 T16013 T16014 arg1Of cells,were
R13027 T16013 T16015 arg2Of cells,incubated
R13028 T16015 T16014 arg2Of incubated,were
R13029 T16015 T16016 arg1Of incubated,with
R13030 T16015 T16026 modOf incubated,followed
R13031 T16015 T16063 arg1Of incubated,but
R13032 T16019 T16016 arg2Of inhibitor,with
R13033 T16019 T16017 arg1Of inhibitor,NF-κB
R13034 T16019 T16018 arg1Of inhibitor,activation
R13035 T16019 T16020 arg1Of inhibitor,(
R13036 T16019 T16023 arg1Of inhibitor,for
R13037 T16021 T16020 arg2Of NAI,(
R13038 T16022 T16020 arg3Of ),(
R13039 T16025 T16023 arg2Of h,for
R13040 T16025 T16024 arg1Of h,1
R13041 T16028 T16026 arg1Of stimulation,followed
R13042 T16028 T16027 arg2Of stimulation,by
R13043 T16028 T16029 arg1Of stimulation,with
R13044 T16030 T16031 arg1Of PMA,(
R13045 T16030 T16039 arg1Of PMA,or
R13046 T16033 T16032 arg1Of nM,162
R13047 T16033 T16034 arg1Of nM,","
R13048 T16034 T16036 arg1Of ",",and
R13049 T16035 T16034 arg2Of A,","
R13050 T16036 T16031 arg2Of and,(
R13051 T16037 T16036 arg2Of C,and
R13052 T16038 T16031 arg3Of ),(
R13053 T16039 T16029 arg2Of or,with
R13054 T16042 T16040 arg1Of coli,HK
R13055 T16042 T16041 arg1Of coli,E.
R13056 T16042 T16043 arg1Of coli,(
R13057 T16042 T16053 arg1Of coli,for
R13058 T16042 T16056 arg1Of coli,(
R13059 T16047 T16048 arg1Of CFU/ml,","
R13060 T16048 T16050 arg1Of ",",and
R13061 T16049 T16048 arg2Of B,","
R13062 T16050 T16043 arg2Of and,(
R13063 T16050 T16044 arg1Of and,5
R13064 T16050 T16045 arg1Of and,×
R13065 T16050 T16046 arg1Of and,107
R13066 T16051 T16050 arg2Of D,and
R13067 T16052 T16043 arg3Of ),(
R13068 T16055 T16053 arg2Of h.,for
R13069 T16055 T16054 arg1Of h.,24
R13070 T16057 T16056 arg2Of A,(
R13071 T16057 T16058 arg1Of A,","
R13072 T16059 T16058 arg2Of B,","
R13073 T16060 T16056 arg3Of ),(
R13074 T16061 T16039 arg2Of NF-κB,or
R13075 T16061 T16042 arg1Of NF-κB,coli
R13076 T16063 T16062 arg1Of but,","
R13077 T16063 T16064 arg1Of but,not
R13078 T16066 T16065 arg2Of C,(
R13079 T16066 T16067 arg1Of C,","
R13080 T16068 T16067 arg2Of D,","
R13081 T16069 T16065 arg3Of ),(
R13082 T16070 T16065 arg1Of AP-1,(
R13083 T16070 T16071 arg1Of AP-1,was
R13084 T16070 T16072 arg2Of AP-1,inhibited
R13085 T16072 T16063 arg2Of inhibited,but
R13086 T16072 T16071 arg2Of inhibited,was
R13087 T16074 T16073 arg1Of significance,Statistical
R13088 T16074 T16075 arg1Of significance,from
R13089 T16074 T16084 arg1Of significance,was
R13090 T16074 T16085 arg2Of significance,determined
R13091 T16078 T16075 arg2Of control,from
R13092 T16078 T16076 arg1Of control,the
R13093 T16078 T16077 arg1Of control,positive
R13094 T16078 T16079 arg1Of control,(
R13095 T16082 T16079 arg2Of coli,(
R13096 T16082 T16080 arg1Of coli,PMA/HK
R13097 T16082 T16081 arg1Of coli,E.
R13098 T16083 T16079 arg3Of ),(
R13099 T16085 T16084 arg2Of determined,was
R13100 T16086 T16085 arg3Of using,determined
R13101 T16087 T16088 arg2Of Student,'s
R13102 T16089 T16086 arg2Of t-test.,using
R13103 T16089 T16088 arg1Of t-test.,'s
R13104 T16089 T16090 arg1Of t-test.,(
R13105 T16091 T16090 arg2Of n,(
R13106 T16091 T16092 arg1Of n,=
R13107 T16091 T16093 arg1Of n,4
R13108 T16094 T16090 arg3Of ),(
R13109 T16095 T16096 arg1Of Controls,were
R13110 T16095 T16097 arg2Of Controls,set
R13111 T16097 T16096 arg2Of set,were
R13112 T16097 T16098 arg1Of set,to
R13113 T16099 T16098 arg2Of 1,to
R13464 T16538 T16539 arg1Of Involvement,of
R13465 T16538 T16543 arg1Of Involvement,in
R13466 T16540 T16541 arg1Of PKC,and
R13467 T16541 T16539 arg2Of and,of
R13468 T16542 T16541 arg2Of JNK,and
R13469 T16545 T16543 arg2Of expression,in
R13470 T16545 T16544 arg1Of expression,cytokine
R13471 T16547 T16546 arg1Of T-cells,Jurkat
R13472 T16547 T16548 arg1Of T-cells,were
R13473 T16547 T16549 arg2Of T-cells,incubated
R13474 T16549 T16548 arg2Of incubated,were
R13475 T16549 T16550 arg1Of incubated,with
R13476 T16549 T16558 modOf incubated,followed
R13477 T16551 T16552 arg1Of PKC-,and
R13478 T16553 T16552 arg2Of JNK,and
R13479 T16554 T16550 arg2Of inhibitors,with
R13480 T16554 T16551 arg1Of inhibitors,PKC-
R13481 T16554 T16553 arg1Of inhibitors,JNK
R13482 T16554 T16555 arg1Of inhibitors,for
R13483 T16557 T16555 arg2Of h,for
R13484 T16557 T16556 arg1Of h,1
R13485 T16558 T16567 arg1Of followed,for
R13486 T16560 T16558 arg1Of stimulation,followed
R13487 T16560 T16559 arg2Of stimulation,by
R13488 T16560 T16561 arg1Of stimulation,with
R13489 T16562 T16561 arg2Of PMA,with
R13490 T16562 T16563 arg1Of PMA,(
R13491 T16565 T16563 arg2Of nM,(
R13492 T16565 T16564 arg1Of nM,162
R13493 T16566 T16563 arg3Of ),(
R13494 T16569 T16567 arg2Of h.,for
R13495 T16569 T16568 arg1Of h.,24
R13496 T16569 T16570 arg1Of h.,(
R13497 T16571 T16570 arg2Of A,(
R13498 T16572 T16570 arg3Of ),(
R13499 T16574 T16573 arg1Of expression,CXCL8
R13500 T16574 T16575 arg1Of expression,was
R13501 T16574 T16576 arg2Of expression,inhibited
R13502 T16576 T16575 arg2Of inhibited,was
R13503 T16576 T16577 arg1Of inhibited,in
R13504 T16580 T16577 arg2Of manner,in
R13505 T16580 T16578 arg1Of manner,a
R13506 T16580 T16579 arg1Of manner,dose-dependent
R13507 T16583 T16576 arg1Of inhibitors.,inhibited
R13508 T16583 T16581 arg2Of inhibitors.,by
R13509 T16583 T16582 arg1Of inhibitors.,both
R13510 T16583 T16584 arg1Of inhibitors.,(
R13511 T16585 T16584 arg2Of B,(
R13512 T16586 T16584 arg3Of ),(
R13513 T16587 T16588 arg1Of JNK-I,revealed
R13514 T16588 T16548 modOf revealed,were
R13515 T16588 T16575 modOf revealed,was
R13516 T16592 T16588 arg2Of effect,revealed
R13517 T16592 T16589 arg1Of effect,a
R13518 T16592 T16590 arg1Of effect,stronger
R13519 T16592 T16591 arg1Of effect,inhibitory
R13520 T16592 T16593 arg1Of effect,on
R13521 T16592 T16596 arg1Of effect,than
R13522 T16595 T16593 arg2Of expression,on
R13523 T16595 T16594 arg1Of expression,IL-6
R13524 T16600 T16599 arg2Of C,(
R13525 T16601 T16599 arg3Of ),(
R13526 T16603 T16597 arg1Of expression,the
R13527 T16603 T16598 arg1Of expression,PKC-I.
R13528 T16603 T16599 arg1Of expression,(
R13529 T16603 T16602 arg1Of expression,TNF
R13530 T16603 T16604 arg1Of expression,was
R13531 T16603 T16606 arg2Of expression,affected
R13532 T16606 T16596 arg2Of affected,than
R13533 T16606 T16604 arg2Of affected,was
R13534 T16606 T16605 arg1Of affected,not
R13535 T16609 T16606 arg1Of inhibitor,affected
R13536 T16609 T16607 arg2Of inhibitor,by
R13537 T16609 T16608 arg1Of inhibitor,either
R13538 T16611 T16610 arg1Of significance,Statistical
R13539 T16611 T16612 arg1Of significance,from
R13540 T16611 T16619 arg1Of significance,was
R13541 T16611 T16620 arg2Of significance,determined
R13542 T16615 T16612 arg2Of control,from
R13543 T16615 T16613 arg1Of control,the
R13544 T16615 T16614 arg1Of control,positive
R13545 T16615 T16616 arg1Of control,(
R13546 T16617 T16616 arg2Of PMA,(
R13547 T16618 T16616 arg3Of ),(
R13548 T16620 T16619 arg2Of determined,was
R13549 T16621 T16620 arg3Of using,determined
R13550 T16622 T16623 arg2Of Student,'s
R13551 T16624 T16621 arg2Of t-test.,using
R13552 T16624 T16623 arg1Of t-test.,'s
R13553 T16624 T16625 arg1Of t-test.,(
R13554 T16626 T16625 arg2Of n,(
R13555 T16626 T16627 arg1Of n,=
R13556 T16626 T16628 arg1Of n,3
R13557 T16629 T16625 arg3Of ),(
R13906 T17076 T17075 arg1Of T-cells,Jurkat
R13907 T17076 T17077 arg1Of T-cells,were
R13908 T17076 T17078 arg2Of T-cells,treated
R13909 T17078 T17077 arg2Of treated,were
R13910 T17078 T17079 arg1Of treated,with
R13911 T17078 T17093 modOf treated,followed
R13912 T17080 T17081 arg1Of 10,nM
R13913 T17082 T17080 arg1Of NAI,10
R13914 T17082 T17083 arg1Of NAI,","
R13915 T17083 T17079 arg2Of ",",with
R13916 T17083 T17090 arg1Of ",",for
R13917 T17089 T17083 arg2Of PKC-I,","
R13918 T17089 T17084 arg1Of PKC-I,10
R13919 T17089 T17085 arg1Of PKC-I,μM
R13920 T17089 T17086 arg1Of PKC-I,JNK-I
R13921 T17089 T17087 arg1Of PKC-I,or10
R13922 T17089 T17088 arg1Of PKC-I,nM
R13923 T17092 T17090 arg2Of h,for
R13924 T17092 T17091 arg1Of h,2
R13925 T17095 T17093 arg1Of induction,followed
R13926 T17095 T17094 arg2Of induction,by
R13927 T17095 T17096 arg1Of induction,with
R13928 T17097 T17098 arg1Of 162,nM
R13929 T17099 T17096 arg2Of PMA,with
R13930 T17099 T17097 arg1Of PMA,162
R13931 T17099 T17100 arg1Of PMA,for
R13932 T17102 T17100 arg2Of h,for
R13933 T17102 T17101 arg1Of h,24
R4194 T5146 T5145 arg1Of induction,Cooperative
R4195 T5146 T5147 arg1Of induction,of
R4196 T5146 T5149 arg1Of induction,by
R4197 T5148 T5147 arg2Of cytokines,of
R4198 T5150 T5151 arg1Of AP-1,and
R4199 T5151 T5149 arg2Of and,by
R4200 T5152 T5151 arg2Of NF-κB,and
R4201 T5155 T5153 arg1Of characterize,To
R4202 T5155 T5154 arg1Of characterize,further
R4203 T5157 T5155 arg2Of involvement,characterize
R4204 T5157 T5156 arg1Of involvement,the
R4205 T5157 T5158 arg1Of involvement,of
R4206 T5157 T5160 arg1Of involvement,in
R4207 T5159 T5158 arg2Of NF-κB,of
R4208 T5162 T5160 arg2Of regulation,in
R4209 T5162 T5161 arg1Of regulation,cytokine
R4210 T5164 T5155 arg1Of we,characterize
R4211 T5164 T5165 arg1Of we,treated
R4212 T5165 T5153 modOf treated,To
R4213 T5165 T5163 arg1Of treated,","
R4214 T5165 T5167 arg1Of treated,with
R4215 T5166 T5165 arg2Of cells,treated
R4216 T5171 T5167 arg2Of inhibitor,with
R4217 T5171 T5168 arg1Of inhibitor,an
R4218 T5171 T5169 arg1Of inhibitor,NF-κB
R4219 T5171 T5170 arg1Of inhibitor,activation
R4220 T5171 T5172 arg1Of inhibitor,(
R4221 T5173 T5172 arg2Of NAI,(
R4222 T5174 T5172 arg3Of ),(
R4223 T5176 T5175 arg1Of results,The
R4224 T5176 T5177 arg1Of results,showed
R4225 T5179 T5181 arg1Of NAI,down-regulated
R4226 T5179 T5191 arg1Of NAI,did
R4227 T5179 T5193 arg1Of NAI,alter
R4228 T5181 T5190 arg1Of down-regulated,and
R4229 T5183 T5181 arg2Of activation,down-regulated
R4230 T5183 T5182 arg1Of activation,NF-κB
R4231 T5183 T5184 arg1Of activation,(
R4232 T5186 T5187 arg1Of 4a,and
R4233 T5187 T5184 arg2Of and,(
R4234 T5187 T5185 arg1Of and,figures
R4235 T5188 T5187 arg2Of 4b,and
R4236 T5189 T5184 arg3Of ),(
R4237 T5190 T5177 arg2Of and,showed
R4238 T5190 T5178 arg1Of and,that
R4239 T5190 T5180 arg1Of and,selectively
R4240 T5193 T5190 arg2Of alter,and
R4241 T5193 T5191 arg2Of alter,did
R4242 T5193 T5192 arg1Of alter,not
R4243 T5195 T5193 arg2Of activity,alter
R4244 T5195 T5194 arg1Of activity,AP-1
R4245 T5195 T5196 arg1Of activity,(
R4246 T5198 T5199 arg1Of 4c,and
R4247 T5199 T5196 arg2Of and,(
R4248 T5199 T5197 arg1Of and,figures
R4249 T5200 T5199 arg2Of 4d,and
R4250 T5201 T5196 arg3Of ),(
R4251 T5202 T5203 arg1Of Exposure,of
R4252 T5202 T5206 arg1Of Exposure,to
R4253 T5202 T5208 arg1Of Exposure,resulted
R4254 T5205 T5203 arg2Of T-cells,of
R4255 T5205 T5204 arg1Of T-cells,Jurkat
R4256 T5207 T5206 arg2Of NAI,to
R4257 T5208 T5209 arg1Of resulted,in
R4258 T5208 T5218 arg1Of resulted,","
R4259 T5208 T5219 arg1Of resulted,while
R4260 T5212 T5209 arg2Of reduction,in
R4261 T5212 T5210 arg1Of reduction,a
R4262 T5212 T5211 arg1Of reduction,modest
R4263 T5212 T5213 arg1Of reduction,of
R4264 T5212 T5215 arg1Of reduction,following
R4265 T5214 T5213 arg2Of CXCL8,of
R4266 T5217 T5215 arg2Of exposure,following
R4267 T5217 T5216 arg1Of exposure,PMA
R4268 T5220 T5221 arg1Of it,did
R4269 T5220 T5223 arg1Of it,alter
R4270 T5223 T5219 arg2Of alter,while
R4271 T5223 T5221 arg2Of alter,did
R4272 T5223 T5222 arg1Of alter,not
R4273 T5226 T5223 arg2Of release,alter
R4274 T5226 T5224 arg1Of release,the
R4275 T5226 T5225 arg1Of release,CXCL8
R4276 T5226 T5227 arg1Of release,following
R4277 T5231 T5227 arg2Of exposure,following
R4278 T5231 T5228 arg1Of exposure,HK
R4279 T5231 T5229 arg1Of exposure,E.
R4280 T5231 T5230 arg1Of exposure,coli
R4281 T5231 T5232 arg1Of exposure,(
R4282 T5234 T5232 arg2Of 5a,(
R4283 T5234 T5233 arg1Of 5a,figure
R4284 T5235 T5232 arg3Of ),(
R4285 T5236 T5237 arg1Of NAI,did
R4286 T5236 T5239 arg1Of NAI,affect
R4287 T5239 T5237 arg2Of affect,did
R4288 T5239 T5238 arg1Of affect,not
R4289 T5239 T5246 modOf affect,indicating
R4290 T5241 T5239 arg2Of expression,affect
R4291 T5241 T5240 arg1Of expression,TNF
R4292 T5241 T5242 arg1Of expression,(
R4293 T5244 T5242 arg2Of 5b,(
R4294 T5244 T5243 arg1Of 5b,figure
R4295 T5245 T5242 arg3Of ),(
R4296 T5248 T5249 arg1Of NF-κB,is
R4297 T5249 T5246 arg2Of is,indicating
R4298 T5249 T5247 arg1Of is,that
R4299 T5249 T5250 arg1Of is,not
R4300 T5253 T5249 arg2Of regulator,is
R4301 T5253 T5251 arg1Of regulator,the
R4302 T5253 T5252 arg1Of regulator,main
R4303 T5253 T5254 arg1Of regulator,of
R4304 T5253 T5258 arg1Of regulator,following
R4305 T5255 T5256 arg1Of CXCL8,or
R4306 T5256 T5254 arg2Of or,of
R4307 T5257 T5256 arg2Of TNF,or
R4308 T5260 T5261 arg1Of PMA,or
R4309 T5261 T5258 arg2Of or,following
R4310 T5261 T5259 arg1Of or,either
R4311 T5261 T5266 arg1Of or,in
R4312 T5265 T5261 arg2Of exposure,or
R4313 T5265 T5262 arg1Of exposure,HK
R4314 T5265 T5263 arg1Of exposure,E.
R4315 T5265 T5264 arg1Of exposure,coli
R4316 T5268 T5266 arg2Of T-cells,in
R4317 T5268 T5267 arg1Of T-cells,Jurkat
R4318 T5270 T5269 arg2Of contrast,In
R4319 T5272 T5273 arg1Of NAI,resulted
R4320 T5273 T5269 arg1Of resulted,In
R4321 T5273 T5271 arg1Of resulted,","
R4322 T5273 T5274 arg1Of resulted,in
R4323 T5273 T5297 arg1Of resulted,","
R4324 T5273 T5298 modOf resulted,suggesting
R4325 T5277 T5274 arg2Of inhibition,in
R4326 T5277 T5275 arg1Of inhibition,a
R4327 T5277 T5276 arg1Of inhibition,complete
R4328 T5277 T5278 arg1Of inhibition,of
R4329 T5277 T5280 arg1Of inhibition,following
R4330 T5279 T5278 arg2Of IL-6,of
R4331 T5282 T5281 arg1Of exposure,PMA
R4332 T5282 T5283 arg1Of exposure,and
R4333 T5283 T5280 arg2Of and,following
R4334 T5285 T5286 arg1Of 45,%
R4335 T5287 T5283 arg2Of inhibition,and
R4336 T5287 T5284 arg1Of inhibition,a
R4337 T5287 T5285 arg1Of inhibition,45
R4338 T5287 T5288 arg1Of inhibition,following
R4339 T5292 T5288 arg2Of exposure,following
R4340 T5292 T5289 arg1Of exposure,HK
R4341 T5292 T5290 arg1Of exposure,E.
R4342 T5292 T5291 arg1Of exposure,coli
R4343 T5292 T5293 arg1Of exposure,(
R4344 T5295 T5293 arg2Of 5c,(
R4345 T5295 T5294 arg1Of 5c,figure
R4346 T5296 T5293 arg3Of ),(
R4347 T5300 T5298 arg2Of involvement,suggesting
R4348 T5300 T5299 arg1Of involvement,an
R4349 T5300 T5301 arg1Of involvement,of
R4350 T5300 T5303 arg1Of involvement,in
R4351 T5302 T5301 arg2Of NF-κB,of
R4352 T5305 T5303 arg2Of regulation,in
R4353 T5305 T5304 arg1Of regulation,IL-6
R4354 T5306 T5307 arg1Of Ca2+,was
R4355 T5306 T5308 arg2Of Ca2+,observed
R4356 T5306 T5310 arg1Of Ca2+,increase
R4357 T5306 T5318 arg1Of Ca2+,reduce
R4358 T5308 T5307 arg2Of observed,was
R4359 T5308 T5325 arg1Of observed,;
R4360 T5310 T5317 arg1Of increase,and
R4361 T5312 T5310 arg2Of activity,increase
R4362 T5312 T5311 arg1Of activity,AP-1
R4363 T5312 T5313 arg1Of activity,(
R4364 T5315 T5313 arg2Of 1c,(
R4365 T5315 T5314 arg1Of 1c,figure
R4366 T5316 T5313 arg3Of ),(
R4367 T5317 T5308 arg3Of and,observed
R4368 T5317 T5309 arg1Of and,to
R4369 T5318 T5317 arg2Of reduce,and
R4370 T5320 T5318 arg2Of activity,reduce
R4371 T5320 T5319 arg1Of activity,NF-κB
R4372 T5320 T5321 arg1Of activity,(
R4373 T5323 T5321 arg2Of 2e,(
R4374 T5323 T5322 arg1Of 2e,figure
R4375 T5324 T5321 arg3Of ),(
R4376 T5328 T5329 arg1Of we,exposed
R4377 T5328 T5339 arg1Of we,determine
R4378 T5329 T5325 arg2Of exposed,;
R4379 T5329 T5326 arg1Of exposed,therefore
R4380 T5329 T5327 arg1Of exposed,","
R4381 T5329 T5331 arg1Of exposed,to
R4382 T5329 T5335 arg1Of exposed,together
R4383 T5329 T5338 modOf exposed,to
R4384 T5330 T5329 arg2Of T-cells,exposed
R4385 T5334 T5331 arg2Of inhibitor,to
R4386 T5334 T5332 arg1Of inhibitor,a
R4387 T5334 T5333 arg1Of inhibitor,PKC
R4388 T5335 T5336 arg1Of together,with
R4389 T5337 T5336 arg2Of PMA,with
R4390 T5339 T5338 arg1Of determine,to
R4391 T5341 T5339 arg2Of effect,determine
R4392 T5341 T5340 arg1Of effect,its
R4393 T5341 T5342 arg1Of effect,on
R4394 T5344 T5342 arg2Of expression,on
R4395 T5344 T5343 arg1Of expression,cytokine
R4396 T5345 T5346 arg1Of Inhibition,of
R4397 T5345 T5348 arg1Of Inhibition,reduced
R4398 T5347 T5346 arg2Of PKC,of
R4399 T5348 T5354 arg1Of reduced,to
R4400 T5348 T5357 arg1Of reduced,while
R4401 T5350 T5348 arg2Of release,reduced
R4402 T5350 T5349 arg1Of release,CXCL8
R4403 T5350 T5351 arg1Of release,from
R4404 T5353 T5351 arg2Of ng/ml,from
R4405 T5353 T5352 arg1Of ng/ml,7
R4406 T5356 T5354 arg2Of ng/ml,to
R4407 T5356 T5355 arg1Of ng/ml,3
R4408 T5358 T5359 arg1Of it,had
R4409 T5359 T5357 arg2Of had,while
R4410 T5359 T5363 arg1Of had,on
R4411 T5362 T5359 arg2Of effect,had
R4412 T5362 T5360 arg1Of effect,a
R4413 T5362 T5361 arg1Of effect,modest
R4414 T5364 T5365 arg1Of IL-6,and
R4415 T5365 T5363 arg2Of and,on
R4416 T5365 T5367 arg1Of and,(
R4417 T5366 T5365 arg2Of TNF,and
R4418 T5369 T5367 arg2Of 6a-c,(
R4419 T5369 T5368 arg1Of 6a-c,figure
R4420 T5370 T5367 arg3Of ),(
R4421 T5371 T5372 arg1Of This,prompted
R4422 T5373 T5372 arg2Of us,prompted
R4423 T5373 T5375 arg1Of us,test
R4424 T5375 T5372 arg3Of test,prompted
R4425 T5375 T5374 arg1Of test,to
R4426 T5377 T5375 arg2Of effect,test
R4427 T5377 T5376 arg1Of effect,the
R4428 T5377 T5378 arg1Of effect,of
R4429 T5377 T5381 arg1Of effect,on
R4430 T5380 T5378 arg2Of inhibition,of
R4431 T5380 T5379 arg1Of inhibition,JNK
R4432 T5384 T5381 arg2Of expression,on
R4433 T5384 T5382 arg1Of expression,PMA-induced
R4434 T5384 T5383 arg1Of expression,cytokine
R4435 T5385 T5386 arg1Of JNK,is
R4436 T5385 T5387 arg2Of JNK,involved
R4437 T5387 T5386 arg2Of involved,is
R4438 T5387 T5388 arg1Of involved,in
R4439 T5387 T5410 arg1Of involved,","
R4440 T5387 T5411 modOf involved,leading
R4441 T5390 T5388 arg2Of regulation,in
R4442 T5390 T5389 arg1Of regulation,the
R4443 T5390 T5391 arg1Of regulation,of
R4444 T5393 T5391 arg2Of multitude,of
R4445 T5393 T5392 arg1Of multitude,a
R4446 T5393 T5394 arg1Of multitude,of
R4447 T5397 T5395 arg1Of factors,different
R4448 T5397 T5396 arg1Of factors,transcription
R4449 T5397 T5398 arg1Of factors,","
R4450 T5397 T5399 arg1Of factors,including
R4451 T5397 T5406 arg1Of factors,","
R4452 T5401 T5402 arg1Of phosphorylation,and
R4453 T5402 T5399 arg2Of and,including
R4454 T5402 T5400 arg1Of and,the
R4455 T5402 T5404 arg1Of and,of
R4456 T5403 T5402 arg2Of activation,and
R4457 T5405 T5404 arg2Of c-Jun,of
R4458 T5406 T5394 arg2Of ",",of
R4459 T5407 T5408 arg1Of c-Fos,and
R4460 T5408 T5406 arg2Of and,","
R4461 T5409 T5408 arg2Of p53,and
R4462 T5411 T5412 arg1Of leading,to
R4463 T5414 T5412 arg2Of apoptosis,to
R4464 T5414 T5413 arg1Of apoptosis,cellular
R4465 T5414 T5415 arg1Of apoptosis,[
R4466 T5416 T5415 arg2Of 26,[
R4467 T5417 T5415 arg3Of ],[
R4468 T5418 T5419 arg1Of Inhibition,of
R4469 T5418 T5423 arg1Of Inhibition,resulted
R4470 T5422 T5419 arg2Of pathways,of
R4471 T5422 T5420 arg1Of pathways,the
R4472 T5422 T5421 arg1Of pathways,JNK
R4473 T5423 T5424 arg1Of resulted,in
R4474 T5423 T5432 arg1Of resulted,","
R4475 T5426 T5424 arg2Of down-regulation,in
R4476 T5426 T5425 arg1Of down-regulation,a
R4477 T5426 T5427 arg1Of down-regulation,of
R4478 T5429 T5430 arg1Of CXCL8,and
R4479 T5430 T5427 arg2Of and,of
R4480 T5430 T5428 arg1Of and,both
R4481 T5431 T5430 arg2Of IL-6,and
R4482 T5433 T5423 arg2Of while,resulted
R4483 T5436 T5434 arg1Of effect,no
R4484 T5436 T5435 arg1Of effect,clear
R4485 T5436 T5437 arg1Of effect,was
R4486 T5436 T5438 arg2Of effect,observed
R4487 T5438 T5433 arg2Of observed,while
R4488 T5438 T5437 arg2Of observed,was
R4489 T5438 T5439 arg1Of observed,on
R4490 T5441 T5439 arg2Of expression,on
R4491 T5441 T5440 arg1Of expression,TNF
R4492 T5441 T5442 arg1Of expression,(
R4493 T5444 T5442 arg2Of 6a-c,(
R4494 T5444 T5443 arg1Of 6a-c,figure
R4495 T5445 T5442 arg3Of ),(
R4496 T5446 T5447 arg1Of Analysis,of
R4497 T5446 T5456 arg1Of Analysis,showed
R4498 T5449 T5447 arg2Of levels,of
R4499 T5449 T5448 arg1Of levels,mRNA
R4500 T5449 T5450 arg1Of levels,using
R4501 T5451 T5450 arg2Of RT-qPCR,using
R4502 T5451 T5452 arg1Of RT-qPCR,(
R4503 T5453 T5452 arg2Of table,(
R4504 T5453 T5454 arg1Of table,2
R4505 T5455 T5452 arg3Of ),(
R4506 T5458 T5459 arg1Of PMA,induced
R4507 T5459 T5456 arg2Of induced,showed
R4508 T5459 T5457 arg1Of induced,that
R4509 T5461 T5462 arg1Of il-6,and
R4510 T5463 T5462 arg2Of cxcl8,and
R4511 T5464 T5459 arg2Of mRNA,induced
R4512 T5464 T5460 arg1Of mRNA,both
R4513 T5464 T5461 arg1Of mRNA,il-6
R4514 T5464 T5463 arg1Of mRNA,cxcl8
R4515 T5464 T5465 arg1Of mRNA,(
R4516 T5466 T5467 arg1Of 5.1-fold,and
R4517 T5467 T5465 arg2Of and,(
R4518 T5467 T5470 arg1Of and,respectively
R4519 T5468 T5467 arg2Of 111.8,and
R4520 T5470 T5469 arg1Of respectively,fold
R4521 T5471 T5465 arg3Of ),(
R4522 T5472 T5473 arg1Of Addition,of
R4523 T5472 T5482 arg1Of Addition,reduced
R4524 T5477 T5474 arg1Of NAI,the
R4525 T5477 T5475 arg1Of NAI,NF-κB
R4526 T5477 T5476 arg1Of NAI,inhibitor
R4527 T5477 T5478 arg1Of NAI,and
R4528 T5478 T5473 arg2Of and,of
R4529 T5481 T5478 arg2Of inhibitor,and
R4530 T5481 T5479 arg1Of inhibitor,the
R4531 T5481 T5480 arg1Of inhibitor,JNK
R4532 T5485 T5482 arg2Of expression,reduced
R4533 T5485 T5483 arg1Of expression,the
R4534 T5485 T5484 arg1Of expression,il-6
R4535 T5485 T5486 arg1Of expression,below
R4536 T5488 T5486 arg2Of levels,below
R4537 T5488 T5487 arg1Of levels,basal
R4538 T5490 T5489 arg2Of contrast,In
R4539 T5495 T5493 arg1Of levels,the
R4540 T5495 T5494 arg1Of levels,cxcl8
R4541 T5495 T5496 arg1Of levels,were
R4542 T5495 T5497 arg2Of levels,suppressed
R4543 T5497 T5492 arg2Of suppressed,while
R4544 T5497 T5496 arg2Of suppressed,were
R4545 T5501 T5497 arg1Of treatments,suppressed
R4546 T5501 T5498 arg2Of treatments,by
R4547 T5501 T5499 arg1Of treatments,the
R4548 T5501 T5500 arg1Of treatments,same
R4549 T5503 T5502 arg1Of levels,the
R4550 T5503 T5504 arg1Of levels,remained
R4551 T5503 T5505 arg1Of levels,elevated
R4552 T5504 T5489 arg1Of remained,In
R4553 T5504 T5491 arg1Of remained,","
R4554 T5504 T5492 arg1Of remained,while
R4555 T5504 T5506 arg1Of remained,above
R4556 T5505 T5504 arg2Of elevated,remained
R4557 T5508 T5506 arg2Of level,above
R4558 T5508 T5507 arg1Of level,basal